Ranked #845 of 8,699 institutional investors
Deerfield Management Company, L.P.
New York, NY
$4.72B
US stock portfolio at live prices · today −$77.0M (−1.60%)
Live prices, last trade 12:42 PM ET
- Value at quarter end (Q3 2026)
- $5.12B
- Change from Q2 2026
- −$2.91B (−36.21%)
- Positions
- 63 · 7 new, 10 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: $1.34B of convertible notes and other principal-amount securities. $187M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesGMAB 7.37%RVMD 7.27%CNC 6.74%UTHR 6.37%PRAX 6.24%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| GMAB Genmab A/S | 6,865,000 | $348M | 7.37% | Unchanged |
| RVMD Revolution Medicines, Inc. | 2,124,000 | $343M | 7.27% | Reduced −11% |
| CNC Centene Corporation | 4,901,000 | $318M | 6.74% | Unchanged |
| UTHR United Therapeutics Corporation | 540,598 | $301M | 6.37% | Added +18% |
| PRAX Praxis Precision Medicines, Inc. | 963,351 | $295M | 6.24% | Unchanged |
| VTRS Viatris Inc. | 10,938,000 | $213M | 4.51% | Reduced −46% |
| COGT Cogent Biosciences, Inc. | 5,957,000 | $161M | 3.41% | Added +19% |
| CELC Celcuity Inc. | 2,397,664 | $131M | 2.77% | Added +65% |
| LEGN Legend Biotech Corporation | 8,137,638 | $125M | 2.64% | Unchanged |
| BMRN BioMarin Pharmaceutical Inc. | 2,025,146 | $123M | 2.60% | Added +52% |
| TNGX Tango Therapeutics, Inc. | 5,180,000 | $114M | 2.42% | Added +24% |
| BCRX BioCryst Pharmaceuticals, Inc. | 15,490,928 | $113M | 2.39% | Added +3% |
| VERA Vera Therapeutics, Inc. | 4,338,778 | $111M | 2.36% | Added +11% |
| LRMR Larimar Therapeutics, Inc. | 35,606,974 | $108M | 2.29% | Unchanged |
| BKD Brookdale Senior Living Inc. | 11,637,032 | $103M | 2.18% | Unchanged |
| CHE Chemed Corporation | 182,000 | $99.7M | 2.11% | Added +507% |
| BSX Boston Scientific Corporation | 2,135,440 | $91.1M | 1.93% | Added +62% |
| ACHC Acadia Healthcare Company, Inc. | 2,493,589 | $85.3M | 1.81% | Reduced −45% |
| AHCO AdaptHealth Corp. | 11,477,730 | $82.9M | 1.76% | Unchanged |
| BIO Bio-Rad Laboratories, Inc. | 226,070 | $81.6M | 1.73% | Unchanged |
| CERT Certara, Inc. | 7,512,928 | $79.7M | 1.69% | Unchanged |
| DNTH Dianthus Therapeutics, Inc. | 914,000 | $77.2M | 1.63% | Reduced −19% |
| IONS Ionis Pharmaceuticals, Inc. | 2,660,669 | $73.0M | 1.55% | Added +34% |
| INSP Inspire Medical Systems, Inc. | 1,296,862 | $72.1M | 1.53% | Unchanged |
| XENE Xenon Pharmaceuticals Inc. | 1,615,696 | $60.1M | 1.27% | Unchanged |
| SVRA Savara Inc. | 13,569,000 | $58.4M | 1.24% | Unchanged |
| MLYS Mineralys Therapeutics, Inc. | 3,958,000 | $55.4M | 1.17% | Unchanged |
| PBLS Parabilis Medicines, Inc. | 1,880,704 | $52.4M | 1.11% | Unchanged |
| IDYA IDEAYA Biosciences, Inc. | 2,003,000 | $51.7M | 1.10% | Reduced −26% |
| NVST Envista Holdings Corporation | 2,210,100 | $50.9M | 1.08% | Unchanged |
| ZTS Zoetis Inc. | 632,000 | $50.6M | 1.07% | New |
| STOK Stoke Therapeutics, Inc. | 1,823,500 | $49.5M | 1.05% | Unchanged |
| IRON Disc Medicine, Inc. | 657,000 | $49.4M | 1.05% | Unchanged |
| ARWR Arrowhead Pharmaceuticals, Inc. | 843,063 | $36.0M | 0.76% | Reduced −39% |
| SNDX Syndax Pharmaceuticals, Inc. | 3,779,900 | $33.8M | 0.72% | Unchanged |
| COO The Cooper Companies, Inc. | 557,000 | $33.0M | 0.70% | New |
| BBNX Beta Bionics, Inc. | 1,903,710 | $25.5M | 0.54% | Added +44% |
| BLTE Belite Bio, Inc | 190,000 | $24.5M | 0.52% | Reduced −47% |
| TNDM Tandem Diabetes Care, Inc. | 1,390,909 | $24.4M | 0.52% | New |
| SPRY ARS Pharmaceuticals, Inc. | 7,503,812 | $23.8M | 0.50% | Unchanged |
| AVLN Avalyn Pharma Inc. | 731,000 | $20.9M | 0.44% | Unchanged |
| BLSM BlossomHill Therapeutics, Inc. | 1,446,000 | $20.9M | 0.44% | New |
| GPCR Structure Therapeutics Inc. | 1,086,000 | $17.9M | 0.38% | Unchanged |
| ODTX Odyssey Therapeutics, Inc. | 1,046,139 | $17.8M | 0.38% | Unchanged |
| ALMR Alamar Biosciences, Inc. | 600,000 | $16.1M | 0.34% | Unchanged |
| EMBC Embecta Corp. | 2,534,961 | $15.6M | 0.33% | Unchanged |
| TYRA Tyra Biosciences, Inc. | 732,392 | $14.6M | 0.31% | Reduced −28% |
| COAG Hemab Therapeutics Holdings, Inc. | 275,000 | $10.8M | 0.23% | Unchanged |
| STLN Starling Oncology, Inc. | 3,360,052 | $10.3M | 0.22% | Unchanged |
| MNPR Monopar Therapeutics Inc. | 137,591 | $9.4M | 0.20% | Reduced −58% |
| VOGX Vogenx, Inc. | 635,707 | $7.7M | 0.16% | New |
| ALHC Alignment Healthcare, Inc. | 1,172,418 | $7.7M | 0.16% | New |
| FHTX Foghorn Therapeutics Inc. | 4,394,367 | $7.7M | 0.16% | Unchanged |
| ETRA Electra Therapeutics, Inc. | 700,000 | $6.0M | 0.13% | New |
| BBOT BridgeBio Oncology Therapeutics, Inc. | 3,138,167 | $5.7M | 0.12% | Reduced −36% |
| DRUG Bright Minds Biosciences Inc. | 236,295 | $4.8M | 0.10% | Reduced −17% |
| ADAG Adagene Inc. | 2,666,666 | $4.4M | <0.1% | Unchanged |
| ALEC Alector, Inc. | 1,055,192 | $2.5M | <0.1% | Unchanged |
| ANNX Annexon, Inc. | 583,913 | $1.8M | <0.1% | Unchanged |
| EW Edwards Lifesciences Corporation | 13,702 | $1.4M | <0.1% | Unchanged |
| MIRM Mirum Pharmaceuticals, Inc. | 6,027 | $588K | <0.1% | Unchanged |
| HUM Humana Inc. | 917 | $363K | <0.1% | Unchanged |
| PMVP PMV Pharmaceuticals, Inc. | 8,790 | $8K | <0.1% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| CDNA CareDx, Inc. | 1,997,618 | $141M |
| PFE Pfizer Inc. | 3,040,000 | $83.6M |
| LNTH Lantheus Holdings, Inc. | 752,999 | $76.9M |
| SUPN Supernus, Inc. | 1,648,895 | $48.2M |
| SGP SpyGlass Pharma, Inc. | 550,000 | $17.1M |
| ALNY Alnylam Pharmaceuticals, Inc. | 67,935 | $10.1M |
| KYTX Kyverna Therapeutics, Inc. | 2,000,000 | $8.5M |
| MOBI Mobia Medical, Inc. | 670,752 | $7.9M |
| VCYT Veracyte, Inc. | 101,000 | $2.6M |
| SION Sionna Therapeutics, Inc. | 680,916 | $2.0M |